SYMPATICO
SYMPATICO: Phase III Trial of Ibrutinib + Venetoclax vs Ibrutinib + Placebo for Patients With R/R Mantle Cell Lymphoma

Released: December 14, 2023

Activity

Progress
1
Course Completed